Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial by Rocca, B, Buck, G, Petrucci, G, Parish, S, Pagliaccia, F, Baigent, C, Mafham, M, Bowman, L, Armitage, J, Patrono, C

Antiplatelet agents for the treatment and prevention of coronary atherothrombosis by Patrono, C, Morais, J, Baigent, C, Collet, J, Fitzgerald, D, Halvorsen, S, Rocca, B, Siegbahn, A, Storey, R, Vilahur, G

Thromboxane biosynthesis and future events in diabetes: the ASCEND trial by Petrucci, G, Buck, GA, Rocca, B, Parish, S, Baigent, C, Hatem, D, Mafham, M, Habib, A, Bowman, L, Armitage, J, Patrono, C

Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis by Rocca, B, Fox, K, Ajjan, R, Andreotti, F, Baigent, C, Collet, J, Grove, E, Halvorsen, S, Huber, K, Morais, J, Patrono, C, Rubboli, A, Seljeflot, I, Sibbing, D, Siegbahn, A, Ten Berg, J, Vilahur, G, Verheugt, F, Wallentin, L, Weiss, T, Wojta, J, Storey, R